Sign in
4

Changes in Ownership

Foghorn Therapeutics Inc. Filed Acc 0001562180-24-000605

Options or other derivatives

  • Chief Legal Officer acquired 100,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
LaCascia Michael Chief Legal Officer 2024-01-24 Grant or award · Stock Option (right to buy) +100,000 $3.06 $306,000 100,000 D
Loading xslF345X05/primarydocument.xml…